Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anus Neoplasms × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 11 Carcinoma, Transitional Cell 11 Colorectal Neoplasms 9 Carcinoma, Merkel Cell 8 Breast Neoplasms 7 Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Small Cell Lung Carcinoma 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Neuroendocrine Tumors 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Turcot syndrome 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Penile Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Melanoma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Neuroendocrine 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thymoma 1

Interventions

Fluorouracil 11 Cisplatin 6 Capecitabine 5 pembrolizumab 4 dehydroftorafur 4 Radiotherapy 4 Radiation 4 Mitomycin 4 Specimen Handling 3 Paclitaxel 3 Drug Therapy 3 Cetuximab 3 Carboplatin 3 Biopsy 3 Radiotherapy, Intensity-Modulated 2 Platinum 2 Nivolumab 2 Mitozytrex 2 Magnetic Resonance Spectroscopy 2 Fluorodeoxyglucose F18 2 1,2-diaminocyclohexaneplatinum II citrate 2 toripalimab 1 tislelizumab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 durvalumab 1 avelumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03944252 2019-07-26

CARACAS

Gruppo Oncologico del Nord-Ovest

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡